Assessment of the Feasibility of Using Noninvasive Wearable Biometric Monitoring Sensors to Detect Influenza and the Common Cold Before Symptom Onset.
Abstract
<h4>Importance</h4>Currently, there are no presymptomatic screening methods to identify
individuals infected with a respiratory virus to prevent disease spread and to predict
their trajectory for resource allocation.<h4>Objective</h4>To evaluate the feasibility
of using noninvasive, wrist-worn wearable biometric monitoring sensors to detect presymptomatic
viral infection after exposure and predict infection severity in patients exposed
to H1N1 influenza or human rhinovirus.<h4>Design, setting, and participants</h4>The
cohort H1N1 viral challenge study was conducted during 2018; data were collected from
September 11, 2017, to May 4, 2018. The cohort rhinovirus challenge study was conducted
during 2015; data were collected from September 14 to 21, 2015. A total of 39 adult
participants were recruited for the H1N1 challenge study, and 24 adult participants
were recruited for the rhinovirus challenge study. Exclusion criteria for both challenges
included chronic respiratory illness and high levels of serum antibodies. Participants
in the H1N1 challenge study were isolated in a clinic for a minimum of 8 days after
inoculation. The rhinovirus challenge took place on a college campus, and participants
were not isolated.<h4>Exposures</h4>Participants in the H1N1 challenge study were
inoculated via intranasal drops of diluted influenza A/California/03/09 (H1N1) virus
with a mean count of 106 using the median tissue culture infectious dose (TCID50)
assay. Participants in the rhinovirus challenge study were inoculated via intranasal
drops of diluted human rhinovirus strain type 16 with a count of 100 using the TCID50
assay.<h4>Main outcomes and measures</h4>The primary outcome measures included cross-validated
performance metrics of random forest models to screen for presymptomatic infection
and predict infection severity, including accuracy, precision, sensitivity, specificity,
F1 score, and area under the receiver operating characteristic curve (AUC).<h4>Results</h4>A
total of 31 participants with H1N1 (24 men [77.4%]; mean [SD] age, 34.7 [12.3] years)
and 18 participants with rhinovirus (11 men [61.1%]; mean [SD] age, 21.7 [3.1] years)
were included in the analysis after data preprocessing. Separate H1N1 and rhinovirus
detection models, using only data on wearble devices as input, were able to distinguish
between infection and noninfection with accuracies of up to 92% for H1N1 (90% precision,
90% sensitivity, 93% specificity, and 90% F1 score, 0.85 [95% CI, 0.70-1.00] AUC)
and 88% for rhinovirus (100% precision, 78% sensitivity, 100% specificity, 88% F1
score, and 0.96 [95% CI, 0.85-1.00] AUC). The infection severity prediction model
was able to distinguish between mild and moderate infection 24 hours prior to symptom
onset with an accuracy of 90% for H1N1 (88% precision, 88% sensitivity, 92% specificity,
88% F1 score, and 0.88 [95% CI, 0.72-1.00] AUC) and 89% for rhinovirus (100% precision,
75% sensitivity, 100% specificity, 86% F1 score, and 0.95 [95% CI, 0.79-1.00] AUC).<h4>Conclusions
and relevance</h4>This cohort study suggests that the use of a noninvasive, wrist-worn
wearable device to predict an individual's response to viral exposure prior to symptoms
is feasible. Harnessing this technology would support early interventions to limit
presymptomatic spread of viral respiratory infections, which is timely in the era
of COVID-19.
Type
Journal articleSubject
HumansRhinovirus
Common Cold
Mass Screening
Early Diagnosis
Biological Assay
Severity of Illness Index
Area Under Curve
Sensitivity and Specificity
Cohort Studies
Feasibility Studies
Biometry
Virus Shedding
Models, Biological
Adult
Female
Male
Influenza, Human
Influenza A Virus, H1N1 Subtype
Young Adult
Wearable Electronic Devices
Permalink
https://hdl.handle.net/10161/23938Published Version (Please cite this version)
10.1001/jamanetworkopen.2021.28534Publication Info
Grzesiak, Emilia; Bent, Brinnae; McClain, Micah T; Woods, Christopher W; Tsalik, Ephraim
L; Nicholson, Bradly P; ... Dunn, Jessilyn (2021). Assessment of the Feasibility of Using Noninvasive Wearable Biometric Monitoring Sensors
to Detect Influenza and the Common Cold Before Symptom Onset. JAMA network open, 4(9). pp. e2128534. 10.1001/jamanetworkopen.2021.28534. Retrieved from https://hdl.handle.net/10161/23938.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
P. Murali Doraiswamy
Professor of Psychiatry and Behavioral Sciences
Murali Doraiswamy MBBS FRCP is Professor of Psychiatry and Professor in Medicine at
Duke University School of Medicine where he is a highly cited physician scientist
at the Duke Institute for Brain Sciences. He is also a Senior Fellow at the Duke
Center for the Study of Aging and an Affiliate Faculty at the Duke Center for Precision
Medicine and Applied Genomics as well as the Duke Microbiome Center. He directs a
clinical trials unit that has been involved in the development of ma
Jessilyn Dunn
Assistant Professor of Biomedical Engineering
Developing new tools and infrastructure for multi-modal biomedical data integration
to drive precision/personalized methods for early detection, intervention, and prevention
of disease.
Geoffrey Steven Ginsburg
Adjunct Professor in the Department of Medicine
Dr. Geoffrey S. Ginsburg's research interests are in the development of novel paradigms
for developing and translating genomic information into medical practice and the integration
of personalized medicine into health care.
Ricardo Henao
Associate Professor in Biostatistics & Bioinformatics
Micah Thomas McClain
Associate Professor of Medicine
Ephraim Tsalik
Adjunct Associate Professor in the Department of Medicine
My research at Duke has focused on understanding the dynamic between host and pathogen
so as to discover and develop host-response markers that can diagnose and predict
health and disease. This new and evolving approach to diagnosing illness has the
potential to significantly impact individual as well as public health considering
the rise of antibiotic resistance.
With any potential infectious disease diagnosis, it is difficult, if not impossible,
to determine at the time of pre
Christopher Wildrick Woods
Wolfgang Joklik Distinguished Professor of Global Health
1. Emerging Infections 2. Global Health 3. Epidemiology of infectious diseases
4. Clinical microbiology and diagnostics 5. Bioterrorism Preparedness 6. Surveillance
for communicable diseases 7. Antimicrobial resistance
Alphabetical list of authors with Scholars@Duke profiles.

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info